Thiopurine therapy
Authors:
- Dermot PB McGovernDMDermot PB McGovern
- Simon Pl TravisSTSimon Pl Travis
- 1 March 2003
- journal article
- Published by Wolters Kluwer Health in European Journal of Gastroenterology & Hepatology
- Vol. 15 (3) , 219-223
Abstract
The thiopurines azathioprine and 6-mercaptopurine are effective both for active disease and for maintaining remission in both Crohn's disease and ulcerative colitis. This review describes criteria for starting thiopurines (two or more courses of steroids in a calendar year, relapse as prednisolone is reduced below 15 mg/day, within 6 weeks of stopping steroids) and the benefits of continuing treatment for up to 5 years. Challenging issues, such as thiopurine intolerance, relative merits of azathioprine, 6-mercaptopurine, monitoring therapy and thiopurines in pregnancy are addressed.Keywords
This publication has 30 references indexed in Scilit:
- Crohn's disease recurrence can be prevented after ileal resectionGut, 2002
- Risk factors for surgery and recurrence in 907 patients with primary ileocaecal Crohn's diseaseBritish Journal of Surgery, 2000
- A multicenter trial of 6-mercaptopurine and prednisone in children with newly diagnosed Crohn's diseaseGastroenterology, 2000
- Operative and environmental risk factors for recurrence of Crohn's disease.International Journal of Colorectal Disease, 1999
- Risk factors for early postoperative recurrence of Crohn's diseaseGastroenterology, 1998
- Post-operative prophylaxis with 6-MP, 5-ASA or placebo in Crohn's disease: A 2 year multicenter trialGastroenterology, 1998
- Effects of cigarette smoking on the long-term course of Crohn's diseaseGastroenterology, 1996
- Surgical recurrence of perforating and nonperforating Crohn's diseaseDiseases of the Colon & Rectum, 1996
- Randomised controlled trial of azathioprine withdrawal in ulcerative colitis.BMJ, 1992
- Predictability of the postoperative course of Crohn's diseaseGastroenterology, 1990